• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨化三醇对透析患者甲状旁腺功能的直接抑制作用(S形曲线)。

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.

作者信息

Dunlay R, Rodriguez M, Felsenfeld A J, Llach F

机构信息

Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.

出版信息

Kidney Int. 1989 Dec;36(6):1093-8. doi: 10.1038/ki.1989.305.

DOI:10.1038/ki.1989.305
PMID:2601258
Abstract

The effect of intravenous calcitriol on parathyroid function was evaluated in nine chronic hemodialysis patients with secondary hyperparathyroidism. Two micrograms of calcitriol were administered intravenously after dialysis thrice weekly for ten weeks. Parathyroid function was assessed by inducing hypo- and hypercalcemia with low calcium (1.0 mEq/liter) and high calcium (4.0 mEq/liter) dialyses before and after ten weeks of intravenous calcitriol therapy. To avoid hypercalcemia during calcitriol administration, the dialysate calcium was reduced to 2.5 mEq/liter. Parathyroid hormone (PTH) values (pg/ml) from dialysis-induced hypo- and hypercalcemia were plotted against serum ionized calcium, and the sigmoidal relationship between PTH and calcium was evaluated. Basal PTH levels fell from 902 +/- 126 pg/ml to 466 +/- 152 pg/ml (P less than 0.01) after therapy without a significant change in the serum total calcium concentration. The ionized calcium-PTH sigmoidal curve shifted to the left and downward after calcitriol therapy. The maximal PTH response during hypocalcemia decreased after calcitriol from 1661 +/- 485 pg/ml before calcitriol to 1031 +/- 280 pg/ml afterward (P less than 0.05). The PTH level at maximal inhibition due to hypercalcemia decreased from 281 +/- 76 pg/ml before calcitriol to 192 +/- 48 pg/ml afterward (P less than 0.05). The slope of the sigmoidal curve changed from -2125 +/- 487 to -1563 +/- 385 (P less than 0.05). The set point of ionized calcium (4.60 +/- .11 mg/dl before vs. 4.44 +/- .07 mg/dl after) did not change significantly with calcitriol therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在9例继发性甲状旁腺功能亢进的慢性血液透析患者中评估了静脉注射骨化三醇对甲状旁腺功能的影响。每周三次透析后静脉注射2微克骨化三醇,持续10周。在静脉注射骨化三醇治疗10周前后,通过低钙(1.0毫当量/升)和高钙(4.0毫当量/升)透析诱导低钙血症和高钙血症来评估甲状旁腺功能。为避免骨化三醇给药期间出现高钙血症,将透析液钙降至2.5毫当量/升。将透析诱导的低钙血症和高钙血症时的甲状旁腺激素(PTH)值(皮克/毫升)与血清离子钙作图,并评估PTH与钙之间的S形关系。治疗后基础PTH水平从902±126皮克/毫升降至466±152皮克/毫升(P<0.01),而血清总钙浓度无显著变化。骨化三醇治疗后,离子钙-PTH S形曲线向左下方移动。骨化三醇治疗后,低钙血症期间的最大PTH反应从骨化三醇治疗前的1661±485皮克/毫升降至1031±280皮克/毫升(P<0.05)。高钙血症导致的最大抑制时的PTH水平从骨化三醇治疗前的281±76皮克/毫升降至192±48皮克/毫升(P<0.05)。S形曲线的斜率从-2125±487变为-1563±385(P<0.05)。骨化三醇治疗后,离子钙的设定点(治疗前4.60±0.11毫克/分升 vs. 治疗后4.44±0.07毫克/分升)无显著变化。(摘要截短于250字)

相似文献

1
Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.骨化三醇对透析患者甲状旁腺功能的直接抑制作用(S形曲线)。
Kidney Int. 1989 Dec;36(6):1093-8. doi: 10.1038/ki.1989.305.
2
Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.静脉注射骨化三醇疗法对继发性甲状旁腺功能亢进控制的长期影响。
Am J Kidney Dis. 1996 Nov;28(5):704-12. doi: 10.1016/s0272-6386(96)90252-8.
3
Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.静脉注射骨化三醇后继发性甲状旁腺功能亢进的改善及钙调定点的降低。
Kidney Int Suppl. 1993 Jun;41:S125-30.
4
The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.长期静脉注射骨化三醇对血液透析患者甲状旁腺功能的影响。
J Am Soc Nephrol. 1991 Nov;2(5):1014-20. doi: 10.1681/ASN.V251014.
5
Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.甲状旁腺功能作为血液透析患者对骨化三醇治疗反应的一个决定因素。
Kidney Int. 1999 Jul;56(1):306-17. doi: 10.1046/j.1523-1755.1999.00538.x.
6
Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.慢性静脉注射骨化三醇对难治性继发性甲状旁腺功能亢进透析患者甲状旁腺功能及钙调定点的影响
Nephrol Dial Transplant. 1992;7(8):822-8.
7
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.骨化三醇与甲状旁腺切除对重度甲状旁腺功能亢进透析患者甲状旁腺激素-钙曲线的不同影响
Nephrol Dial Transplant. 1996 Jan;11(1):81-7.
8
Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.低转换型铝骨病血液透析患者甲状旁腺激素对低钙血症反应的滞后现象。
J Am Soc Nephrol. 1991 Dec;2(6):1136-43. doi: 10.1681/ASN.V261136.
9
Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.骨化三醇与甲状旁腺激素 - 离子钙曲线:方法学比较
J Am Soc Nephrol. 1996 Mar;7(3):497-505. doi: 10.1681/ASN.V73497.
10
Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.骨化三醇治疗及撤药对伴有低钙血症的血液透析患者甲状旁腺功能亢进的影响。
Nephrol Dial Transplant. 2001 May;16(5):1009-16. doi: 10.1093/ndt/16.5.1009.

引用本文的文献

1
Mathematical Models of Parathyroid Gland Biology: Complexity and Clinical Use.甲状旁腺生物学的数学模型:复杂性与临床应用
Front Nephrol. 2022 May 18;2:893391. doi: 10.3389/fneph.2022.893391. eCollection 2022.
2
A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.一名继发性甲状旁腺功能亢进的血液透析患者,对依特卡塞治疗抵抗,但对盐酸西那卡塞有反应。
CEN Case Rep. 2022 May;11(2):254-258. doi: 10.1007/s13730-021-00664-0. Epub 2021 Nov 17.
3
Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.
继发性甲状旁腺功能亢进症:发病机制、诊断、预防和治疗策略。
Rev Endocr Metab Disord. 2017 Mar;18(1):79-95. doi: 10.1007/s11154-017-9421-4.
4
Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease.选择性维生素 D 受体激活作为慢性肾脏病的抗炎靶点。
Mediators Inflamm. 2014;2014:670475. doi: 10.1155/2014/670475. Epub 2014 Jan 6.
5
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.帕立骨化醇和西那卡塞对慢性肾脏病大鼠血清磷酸盐、FGF-23 和骨的影响。
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1315-22. doi: 10.1152/ajprenal.00552.2009. Epub 2010 Mar 3.
6
Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.慢性肾衰竭患儿的继发性甲状旁腺功能亢进:发病机制与治疗
Paediatr Drugs. 2003;5(11):763-76. doi: 10.2165/00148581-200305110-00005.
7
Vitamin D and its analogs in chronic renal failure.维生素D及其类似物与慢性肾衰竭
Osteoporos Int. 1997;7 Suppl 3:S202-8. doi: 10.1007/BF03194373.
8
1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients.1,25-二羟胆钙化醇脉冲疗法及不同透析膜对血液透析患者血清甲状旁腺激素水平的影响
Int Urol Nephrol. 1997;29(2):251-8. doi: 10.1007/BF02551351.
9
Parathyroid gland function in secondary hyperparathyroidism.
Pediatr Nephrol. 1996 Jun;10(3):359-63. doi: 10.1007/BF00866785.
10
Intact parathyroid hormone levels in renal insufficiency.肾功能不全时甲状旁腺激素水平完整情况
Calcif Tissue Int. 1995 Nov;57(5):329-35. doi: 10.1007/BF00302067.